Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron hydrochloride injection for prevention of chemotherapy-induced gastrointestinal reactions (Phase II)
CTR20132597Phase 2Active
- Sponsor
- Changchun High-Tech
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Changchun High-Tech. Started Apr 2014; status: active.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on CTR20132597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132597.